- On May 26, 2020, the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) issued joint warning letters to four companies for the marketing and sale of products
DIETARY SUPPLEMENTS
FDA Provides Congressionally-Mandated Cannabidiol (CBD) Report but Reveals Little Progress
Posted on
- We have discussed a public hearing that FDA held on May 31, 2019 to obtain scientific data and safety information on the wide array of FDA-regulated products already on the
Bipartisan Group of Representatives Introduces Bill that Would Give FDA Authority to Regulate CBD as a Dietary Supplement (Law360 subscription required)
Posted on
- On January 13, 2020, the House Agriculture Committee Chairman Collin Peterson (D- Minn.) introduced H.R. 5587, which would include hemp derived CBD in the definition of dietary supplements under
11th Circuit Rules for Plaintiffs in Class Action Lawsuit Based on Economic Loss From Purchase of ‘Worthless’ Supplements Containing DMBA – an Impermissible NDI
Posted on
- We previously reported on a flurry of FDA enforcement actions in 2015 based on adulteration per se, which followed years of relative inaction in the dietary supplement marketing arena outside
Trade Associations Send Letter to All Members of Congress Urging Action on CBD in Dietary Supplements
Posted on
- On October 8, the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance – a group of trade associations
USDA Seeks Public Input Ahead of 41st Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU)
Posted on
- The U.S. Department of Agriculture (USDA) announced on September 24 that it will hold a public meeting to provide interested parties an opportunity to address items on the agenda of
FDA Announces Modernization of NDIN Electronic Submission System
Posted on
- FDA has announced that it is launching a new electronic submission system for New Dietary Ingredient Notifications (NDINs) on Friday, September 6. The new system, the CFSAN Online Submission Module
…
Continue Reading FDA Announces Modernization of NDIN Electronic Submission System
FDA Exploring Additional Regulatory Pathways for CBD Products
Posted on
- In testimony before the U.S. Senate Committee on Agriculture, Nutrition, and Forestry on July 25, FDA’s Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., reiterated that FDA “is committed to advancing
…
Continue Reading FDA Exploring Additional Regulatory Pathways for CBD Products
FDA Reiterates That Scientific Data and Safety Information are Required to Support a Regulation or Formal Enforcement Discretion Policy on the Use of CBD in Foods
Posted on
- Many businesses are already capitalizing on a surge in the popularity of cannabidiol (CBD) products and are pressuring the Food and Drug Administration (FDA) for a regulatory path to
CBD in Foods: FDA Requests More Safety Data; Industry Wants Clear Regulatory Path
Posted on
- Under current law, cannabidiol (CBD) cannot lawfully be added to a food or marketed as a dietary supplement, Acting FDA Commissioner, Ned Sharpless, MD, emphasized during remarks he made at
…
Continue Reading CBD in Foods: FDA Requests More Safety Data; Industry Wants Clear Regulatory Path